PubMed

Insulin secretion in type 1 diabetes.

Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, Donaldson D, Harlan DM, Bluestone J, Herold KC.

Diabetes. 2004 Feb;53(2):426-33.PMID: 14747294 [PubMed - indexed for MEDLINE]Related articlesFree article

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK.

JAMA. 2007 Apr 11;297(14):1568-76.PMID: 17426276 [PubMed - indexed for MEDLINE]Related articlesFree article

Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.

Pörksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, Holst JJ, Ploug KB, Hougaard P, Hansen L, Mortensen HB; Hvidøre Study Group on Childhood Diabetes.

J Clin Endocrinol Metab. 2007 Aug;92(8):2910-6. Epub 2007 May 22.PMID: 17519307 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.

Taha D, Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2006 Feb;19(2):135-42.PMID: 16562586 [PubMed - indexed for MEDLINE]Related articles

Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes.

Brown RJ, Sinaii N, Rother KI.

Diabetes Care. 2008 Jul;31(7):1403-4.PMID: 18594062 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.

Krarup T, Madsbad S, Moody AJ.

J Clin Endocrinol Metab. 1985 Jan;60(1):120-5.PMID: 3880559 [PubMed - indexed for MEDLINE]Related articles

Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA.

Diabetes Care. 2009 May;32(5):866-72. Epub 2009 Feb 5.PMID: 19196896 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

Mari A, Tura A, Gastaldelli A, Ferrannini E.

Diabetes. 2002 Feb;51 Suppl 1:S221-6.PMID: 11815483 [PubMed - indexed for MEDLINE]Related articlesFree article

C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.

Umpaichitra V, Bastian W, Taha D, Banerji MA, AvRuskin TW, Castells S.

J Clin Endocrinol Metab. 2001 Apr;86(4):1605-9.PMID: 11297591 [PubMed - indexed for MEDLINE]Related articlesFree article

Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity.

Le Stunff C, Bougnères P.

Diabetes. 1994 May;43(5):696-702.PMID: 8168647 [PubMed - indexed for MEDLINE]Related articles

Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.

Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.

Scand J Clin Lab Invest. 2007;67(3):327-36.PMID: 17454847 [PubMed - indexed for MEDLINE]Related articles

Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

Diabetes Care. 2006 May;29(5):1031-8.PMID: 16644633 [PubMed - indexed for MEDLINE]Related articlesFree article

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.

Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA.

Diabetes. 2005 Jun;54(6):1763-9.PMID: 15919798 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.

Blackman JD, Polonsky KS, Jaspan JB, Sturis J, Van Cauter E, Thistlethwaite JR.

Diabetes. 1992 Oct;41(10):1346-54.PMID: 1397710 [PubMed - indexed for MEDLINE]Related articles

[Factors affecting C-peptide level during the first year of type 1 diabetes in children]

Zmysłowska A, Szadkowska A, Andrzejewski W, Wegner O, Wyka K, Młynarski W, Bodalski J.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):103-11. Polish. PMID: 15504313 [PubMed - indexed for MEDLINE]Related articlesFree article

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.

Polonsky KS, Given BD, Van Cauter E.

J Clin Invest. 1988 Feb;81(2):442-8.PMID: 3276730 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

Horm Metab Res. 2006 Oct;38(10):668-72.PMID: 17075776 [PubMed - indexed for MEDLINE]Related articles

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA.

N Engl J Med. 2002 May 30;346(22):1692-8.PMID: 12037148 [PubMed - indexed for MEDLINE]Related articlesFree article

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G.

Diabetologia. 2000 Aug;43(8):1000-4.PMID: 10990077 [PubMed - indexed for MEDLINE]Related articles